Corentec Co., Ltd.
KKRX:1045404,990.00
KRW
+160.00
(+3.31%)
ISIN
KR7104540000
Return %
Stock
S&P 500
1Y
-6.20
14.39
3Y
-53.28
81.42
5Y
-65.59
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Bon-Cheol Koo
- Full Time Employees
- 181
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Cheonan South Korea
- IPO Date
- Mar 5, 2013
- Website
- corentec.com
- Similar Companies
- Business
- Corentec Co., Ltd. is a South Korea-based medical device company primarily engaged in the research, development, manufacturing, and commercialization of orthopedic implants, surgical instruments, and advanced biomedical solutions. Founded in 2000 and headquartered in Cheonan, South Korea, the company specializes in joint reconstruction and musculoskeletal therapeutics. Corentec operates across multiple specialized product categories: artificial hip joint systems, including cementless and cemented femoral stems, acetabular cups, modular liners, and ceramic or metallic heads marketed under the BENCOX and Mirabo brand series; artificial knee joint systems, comprising primary, revision, and mobile-bearing total knee arthroplasty implants marketed under the LOSPA and EXULT brand lines; artificial shoulder joint replacement prostheses; spinal fusion devices and posterior fixation systems; orthobiologics, including bone graft substitutes, orthopedic bone cements, and biomaterial coatings; and specialized orthopedic surgical instrument sets, patient-specific cutting guides, and custom 3D-printed titanium implants. The company serves hospitals, surgical centers, and healthcare providers globally, maintaining international operations and commercial subsidiaries, including Corentec America, Inc. in the United States, with distribution networks spanning North America, Europe, the Asia-Pacific region, and Latin America. In recent developments, Corentec has accelerated its international market expansion by securing broadened regulatory approvals and commercializing upgraded total knee and hip replacement systems in the United States and global territories. The company has also formed strategic collaborations to integrate digital orthopedics and robotic-assisted surgical navigation technologies with its implant platforms, expanded its metal 3D-printing manufacturing infrastructure for custom implants, and reinforced its distribution partnerships to scale adoption across major hospital networks worldwide.